In C difficile infection, adding IV bezlotoxumab to standard antibiotics reduced recurrence at 12 weeks
A commentary in ACP Journal Club noted that it would be reasonable to consider fidaxomicin or bezlotoxumab in patients at high risk for recurrent Clostridium difficile infection or in those for ... 1 ACP Hospitalist Weekly. The following commentary by
Clinical judgment will be needed to determine whether the relatively modest improvement in outcomes will be important to patients for whom the drug is considered, according to an accompanying ACP Journal ... The following commentary by Sander Veldhuyzen
Glasgow Blatchford score predicted intervention or death better than 4 other prediction models in upper GI bleeding
Commentary authors writing in ACP Journal Club said the findings add to a growing body of literature that supports the use of the Glasgow Blatchford score for selecting low-risk patients ... The following commentary by Nicholas Talley, MD, PhD, FRACP,
In Barrett esophagus, high- vs low-dose esomeprazole improved clinical outcomes; aspirin vs no aspirin did not
ACP Journal Club commentary said. ... The following commentary by John K. Marshall, MD, MSc, FRCPC, appeared in the ACP Journal Club section of the Nov.
The results of the randomized trial do not support routinely recommending aspirin before fecal immunochemical testing for colorectal cancer screening, according to an ACP Journal Club commentary. ... Fletcher, MD, MACP, MSc, appeared in the ACP Journal
The results of this randomized trial do not support current guidelines, which recommend withholding antiplatelet drugs to reduce risk for postpolypectomy bleeding, an ACP Journal Club commentary said. ... The following commentary by David Lichtenstein, MD
or no treatment in a randomized trial, according to an ACP Journal Club commentary. ... The following commentary by Ronald L. Koretz, MD, FACP, appeared in the ACP Journal Club section of the Sept.
very small benefit from long-term proton-pump inhibitor therapy, an ACP Journal Club commentary said. ... The following commentary by Pradeep Dayanand, MD, and Steven Borzak, MD, appeared in the ACP Journal Club section of the Oct.
The trial results cannot be generalized to all patients with cirrhosis, and future trials should look at whether similar effects could be achieved simply by limiting salt intake, an ACP Journal ... The following commentary by Jacob Korula, MD, FACP,